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Individuals with a developmental disability will experience the same 
health issues associated with the normal ageing process 1 and will 
require similar services from their doctor as any other ageing person. 
However, they may have additional unique needs depending on the 
aetiology of their disability, their environmental history, their 
lifestyle, eg exercise, diet, and their patterns of medication usage. 1 
It is important to be sensitive to these additional needs .. 
This chapter will focus on issues pertinent to ageing adults with a 
developmental disability, and issues that may be overlooked due to 
communication difficulties or a lack of training or awareness of 
ageing and health issues. 2 
AGEING AND SYNDROMES 
Some syndromes associated with developmental disability are known 
to have specific health issues related to ageing. A recent study 
suggested that adults with cerebral palsy experienced physical 
changes that they attributed to an early ageing process. 3 Individuals 
with Down syndrome may also experience precocious ageing and the 
incidence of Alzheimer's disease is higher in individuals with Down 
syndrome than the rest of the population including those with an 
intellectual disability. 1 
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BARRIERS TO CARE 
Many health management issues are the same for all individuals who 
are ageing. However, clinical management of ageing adults with a 
developmental disability is often complicated. 
Communication impairments can cause difficulties in obtaining an 
accurate history and performing examinations. 
Family members are often unaware of changes that occur during the 
ageing process 1 and may attribute problems to the disability or 
behaviour rather than a change in health status, secondary to ageing. 
Carers who are not family members may have a limited 
understanding of ageing, as they themselves are often young and 
untrained 1•3 and may have limited knowledge of the individual for 
whom they are caring. 
Older adults with a developmental disability may have frequent 
changes in carers 4 and residential location, and health records are 
often inadequate. 1 Consequently, it may take some time to piece 
together an accurate picture of the individual's health status. 
Recommendation 
Every older person with a developmental disability needs to be 
evaluated as an individual and the doctor should encourage 
individuals and their carers to keep careful records and to 
attend the practice regularly so that over time the doctor, 
individual and carer build up a good rapport. 
POLYPHARMACY 
As developmentally disabled adults age they are likely to develop 
medical problems requiring additional medications. These are often 
in addition to an established medication regimen. Interactions 
between their new and existing medications can cause problems, 
while changes in the metabolism and excretion of their current drug 
regimes will need to be considered. 
DRUG METABOLISM 
Changes in drug utilisation occur with ageing. Absorption is 
minimally affected. Metabolism, excretion and bioavailability all 
change with ageing, and are discussed in the next section. As adults 
age their drug metabolism rate slows secondary to changes in liver 
metabolism. 
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Hepatic oxidative activity decreases with age . 
Liver volume decreases significantly with age . 
Hepatic blood flow decreases with age. 5 
The liver metabolises drugs through two processes. 6 The first process 
introduces a polar (water-soluble) group into the drug molecule by 
one or more of the following processes: oxidation; reduction; 
demethylation; hydroxylation. 
Sites on the drug molecule are now made available for the second 
process, conjugation. The second process includes acetylation 
( eg isoniazid), glucuronidation ( eg paracetamol) and sulfation. 
Some drugs go through both phases. 
Although current research debates this, the alterations in oxidative 
metabolism of some drugs in older people may prolong the duration 
of action of drugs such as diazepam, propranolol, chlordiazepoxide 
and theophylline. 
Be Aware 
Be aware of possible adverse drug reactions due to the prolonged 
duration of action and note that a reduced dose may be required. 
Table 13 Some drugs that are affected by age-related changes 
in hepatic metabolism 
Half-life 
chlordiazepox:ide 
chlormethiazole 
desipramine* 
diazepam* 
lorazepam* 
metoprolol* 
nitrazepam* 
paracetamol 
quinidine 
Clearance 
chlordiazepoxide 
chlormethiazole 
imipramine 
metoprolol 
nortriptyline* 
paracetamol 
phenytoin* 
propranolol 
* conflicting results from independent studies by different authors 
DRUG EXCRETION 
Advancing age produces a decline in renal function. From 20 to 90 
years glomerular filtration rate decreases by 46 percent, renal blood 
flow decreases by 53 percent and tubular excretion decreases by 44 
percent. 
Dehydration, cardiac failure, hypotension and urinary retention may 
further decrease excretory capacity. Therefore drugs predominantly 
excreted in the urine may have prolonged duration of action and are 
more likely to reach toxic levels unless their dose is reduced. 
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Table 14 Some drugs predominantly excreted by the kidney 6 
aciclovir 
amantadine 
amiloride 
aminoglycosides 
amoxycillin 
ampicillin 
atenolol 
cephalexin* 
chlorpropamide 
cimetidine* 
ciprofloxacin 
disopyrarnide 
enalapril 
famotidine 
lithium* 
methotrexate 
metoclopramide 
norfloxacin* 
penicillin 
pyrazinamide 
ranitidine 
captopril irnipenern tetracycline* 
*drugs known to have age-related reduction in renal excretion 
RECEPTOR SENSITIVITY 
Older people become more sensitive to the effects of medication 7 
possibly due to central receptor sensitivity changes. Toxic 
confusional states and postural hypotension secondary to medication 
adverse effects are more common in the elderly than younger people. 
This may be because of changes to the autonomic nervous system 
and brain acetylcholine levels. There is also an increased sensitivity 
to benzodiazepines with age via central gamma-aminobutyric acid 
receptor changes. 6 
Some drugs acting through receptor pathways include tricyclic 
antidepressants, phenothiazines, diuretics, nitrazepam, diazepam, 
hypnotics and propantheline. 
Note: Lower doses of phenothiazines and psychotropic 
medications are often required. 
BIOAVAILABILITY 
The changes described in previous paragraphs coupled with a 
reduction in lean body mass, relative increase in body fat and 
impaired plasma protein binding result in a longer half-life for many 
medications. 
Many drugs are stored in fat; in older people, as fat replaces muscle, 
drug storage is prolonged and the drug is eliminated more slowly. 
Protein binding is very significant. The less plasma protein available 
for binding the more unbound drug there will be and therefore the 
more likely toxic effects are to occur. Thus, malnourished people and 
those with protein loss due to disease are vulnerable to intoxication. 
Many adults with a developmental disability take prescribed 
medication and may have done so for much of their lives. In addition, 
they may take a number of over-the-counter medications and herbal 
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preparations that they do not discuss with their doctor. 8 Thus, 
adverse effects from medications can occur if dosages are not 
readjusted1 or if several different substances interact adversely. 
Table 15 Some highly protein-bound drugs 6 
Drug 
amitriptyline 
chlorpromazine 
diazepam 
fluoxetine 
phenytoin 
promethazine 
tolbutamide 
warfarin 
MANAGEMENT 
Percent bound to albumin 
96 
99 
99 
95 
91 
95 
95 
97 
Review medication regularly and cease any that is not necessary. 
Review indication for use of medication, especially neuroleptics used 
for challenging behaviours. Treat the cause where possible rather 
than symptom modification. Readjust medication dosage to lowest 
necessary for the desired treatment effect with metabolic and 
excretion changes in mind. 
• Regularly monitor renal function and serum levels of appropriate 
drugs, eg lithium, antiepileptics. 
• Encourage the individuals/carers to discuss all therapeutic 
substances taken, including over-the-counter preparations, 
herbal remedies and other doctors' prescriptions. 
• Maintain close liaison with the patient's other prescribers, eg 
specialists, hospital medical staff. 
• Encourage the individual to access one pharmacist and one 
doctor for all the therapeutic substances and request the 
pharmacist to note over-the-counter preparations purchased as 
well as prescribed drugs. 
• Consider reports of changes in behaviour or mood and reports of 
confusion in the light of adverse drug reactions or toxic levels of 
medication. 
VISION AND HEARING IMPAIRMENT 
Decline in vision and hearing is common in older people 8 with 60 
percent of individuals over 65 experiencing presbycusis and some 
also suffering from tinnitus. 
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Such losses can result in social isolation, confusion, and apparent 
loss of skill, and in the case of visual changes an increased risk for 
falling. Older adults with a developmental disability may be unable to 
report sensory losses and may be unaware of how such losses impact 
on their ability to function in their environment. In addition, carers 
may attribute nonresponse to behavioural aspects ( eg stubbornness) 
rather than to a sensory impairment. 
• Ensure regular hearing and vision assessments by service 
providers specialised in dealing with people with disabilities. 
• Advise family members and carers on good communication 
practice; consult the Australian Hearing Services or a speech 
therapist. 
• Ensure that carers understand that older individuals require 
well-lit areas and glare-free environments in order to function 
safely and optimally. 
• Referral to a speech therapist may be beneficial if 
communication is impaired by sensory loss or the individual is 
having difficulty in seeing or using his/her communication aid. 
SKIN AND TEMPERATURE HOMEOSTASIS 
Older people's skin becomes paler, wounds do not heal as quickly and 
skin becomes more vulnerable to sun damage. 7 It is also less able to 
produce sweat. Adults with a developmental disability may not be 
aware of the importance of wearing sunscreen and that some 
medication, such as certain neuroleptics, may make them more 
vulnerable to sunburn. 8 
A decrease in the number of sweat glands in the older individual also 
means that heat dissipation is more difficult. In addition 1 age-
associated breakdown in collagen and elastin fibres result in thinner, 
less pliable skin with less subcutaneous fat. This interferes with 
insulation and older individuals are more susceptible to cold. 7•8 
Individuals with disabilities may not voice their discomfort or may 
not be able to rectify the situation themselves. 
Older adults experience less thirst, therefore they have an increased 
risk for dehydration and heat stroke. 8 The risk for older adults with a 
developmental disability may be increased as they may have 
difficulty drinking 2 and may also avoid drinking in an effort to 
manage incontinence. 
• Provide health promotion on the importance of sunscreen and 
not staying out in the sun for long periods. 
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• Ensure that carers are aware of the importance of monitoring an 
individual's body heat, and avoidance of long periods unattended 
in either the sun or shade. 
• Help carers understand the importance of ensuring that the 
individual is warmly/coolly dressed as appropriate and that the 
need for more or less clothing can change quickly, eg moving 
from a sunny verandah into the house. 
• Ensure that the individual or carers understand the importance 
of adequate fluid intake during warm weather. 
CONSTIPATION 
Many individuals with a developmental disability have poor bowel 
function as a result of poor toiletting habits, lack of dietary fibre, 
inadequate intake of liquid, inactivity or medications, eg 
phenothiazines, verapamil. 1·8 The general population tends to lose 
bowel motility in the ageing process, thus individuals with a 
developmental and/or physical disability are at risk of severe 
problems with constipation that can result in both physical and 
behavioural problems. 
Educate the individuals and carers on the importance of exercise, 
adequate intake of dietary fibre and fluid. Assisting the individuals to 
develop regular bowel habits and monitoring bowel output regularly 
are also important. A change in bowel habit might be an indication of 
the development of bowel pathology. See the chapter, Adult 
Healthcare, p.47, for specific therapies. 
URINARY INCONTINENCE 
Urinary incontinence is very frequent in older age groups, but is not 
part of the normal ageing process. It is usually caused by a treatable 
medical problem such as an infection, although it is commonly 
mistaken for a behavioural problem, eg attention-seeking behaviour. 
Communication difficulties, mobility and cognitive problems 
complicate management. 
For assessment and management of urinary incontinence, see the 
chapter, Adult Healthcare, p.47. 
CARDIOVASCULAR AND 
CEREBROVASCULAR DISEASE 
The incidence of cardiovascular and cerebrovascular disease in 
individuals with a developmental disability (excluding people who 
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have Down syndrome) appears similar to that of an ageing population 
without developmental disability. Most common are congestive 
cardiac failure, ischaemic heart disease and cerebrovascular 
accident. However, the incidence of hypertension is lower. 
• Manage cardiovascular problems as for older people without 
disability. 
• Identify cardiovascular risk factors. 
• Provide regular physical assessments, especially blood pressure 
and obesity. 
• Implement health promotion, eg weight control through dietary 
and nutritional advice and exercise. 
Be Aware 
Obstacles such as communication difficulties and polypharmacy 
may mask the underlying diagnosis. Accurate diagnosis and 
management can be difficult. 
Symptom presentation can be altered by developmental 
disability. 
EPILEPSY 
Persons with a lifelong history of epilepsy and antiepileptic therapy 
are at increased risk of osteoporosis and consequently fractures. 1 
Drug interactions can affect therapeutic blood levels. Phenytoin can 
cause folate deficiency. 
For management guidelines see the chapter, Epilepsy, p.131. 
• Monitor medication by serum levels and minimise adverse 
reactions. 
• Educate the individuals and carers on the importance of weight-
bearing exercise. 
• Educate the individual and carers on the importance of adequate 
vitamin D intake. 
• Ensure that the individual has adequate calcium intake. 
• Provide appropriate treatment of osteoporosis after diagnosis. 
CONFUSION 
Acute confusional states are common in ageing individuals with an 
intellectual disability. Many conditions can present as confusion 
including depression, 1 delirium, dementia and pain. 
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Delirium resulting from acute illness such as infection, myocardial 
infarction, or drug toxicity, can be mistaken for a behavioural 
problem by carers and staff. Evaluation of dementia or new cognitive 
impairments is more difficult secondary to underlying or baseline 
intellectual impairment. Rate of onset of the confusional state, 
attention to acute illness and associated features helps in accurate 
diagnosis. 
• Establish whether the confusion is of recent onset or developed 
over a longer period of time. 
• Evaluate medication levels. 
• Screen for acute illness, metabolic disorder, infections, 
myocardial infarction, cerebrovascular accident, thyroid 
deficiency and vitamin B 12 deficiency. 
• Assess for slow onset of global impairment that may indicate 
dementia, taking into account baseline intellectual ability. 
• Assess for depression, with attention to mood, appetite and level 
of activity. 
• Refer for neuropsychological assessment for in-depth evaluation 
if necessary. 
• Refer to Aged Care Assessment Team or Aged Psychiatry 
Assessment and Treatment Team for specialist evaluation if 
necessary. 
GRIEF, BEREAVEMENT AND DEPRESSION 
Old age is a time of loss and bereavement for people with a 
developmental disability3•9 just as for those without a disability. 4·7 
The prevalence of psychiatric illness in people with an intellectual 
disability is known to be high, and people with an intellectual 
disability appear to be particularly vulnerable to depressive illness. 
• Adults with developmental disabilities may experience long 
periods of grief and depression, particularly at a time of loss and 
this may not be recognised. 
• Older people with an intellectual disability may verbalise that all 
is well when it is not and carers often take such statements at 
their face value. 
• Atypical presentations are common and accurate diagnosis of 
depression can be missed, eg behaviour considered to be a form 
of challenging behaviour. 9 
• The spectrum of depressive disorders range from minor 
depressive symptoms to life threatening depressive illness. 9 
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• The suicide rate in Australia is highest for men aged 75 and over 
but little is known of the potential suicidal behaviour or suicidal 
feelings of adults with a developmental disability. 10 
Be Aware 
It may be difficult to differentiate between depression, early 
stages of dementia and individuals that are reacting to sensory 
and/or environmental deprivation or sudden life changes. 
Dementia, particularly Alzheimer's disease, may be 
overdiagnosed while depression may be underdiagnosed. 9 
ASSESSMENT 
The following issues should be investigated. 
• Rate of onset (dementia is slow, depression can be fast). 
• Whether the individual has suffered recent loss, including 
bereavement, change of living arrangements, change of carers, or 
losses that may have occurred at a much earlier age. 
• Whether there is a history of childhood abuse. 
• Whether there is a history of substance abuse. 
• Previous history of depression or family history of mental illness. 
• Review current medication. 
MANAGEMENT 
• Explain to the family/carers the different stages of grief and how 
they may be manifested. 
• Encourage family/carers to allow the individual to express his/her 
grief and if necessary refer to an experienced grief counsellor. 
• Provide appropriate antidepressant medication. 
• Monitor any prescribed medication carefully and ensure that no 
other substances are being taken that may react adversely with 
new medication. 
• Provide appropriate referral to a multidisciplinary team skilled in 
managing psychiatric disorders in older disabled people, such as 
the Aged Psychiatry Assessment and Treatment Team (formerly 
the Psychogeriatric Assessment). 
• If necessary, refer to a psychiatrist (preferably one experienced 
in working with people with intellectual or developmental 
disabilities). 
70 
Aged Care 
ACCESS AND ENVIRONMENT 
Although matters relating to access are traditionally dealt with by 
occupational therapists and physiotherapists, the doctor may need to 
advise individuals and their carers on environmental modifications 
that will improve the quality of life of an ageing person with a 
developmental disability. The following points may require 
consideration. 
LIGHTING 
Older individuals typically require more light to see adequately but 
are susceptible to glare. Blinds and curtains that diffuse light may be 
helpful. Shiny polishes and paints should be avoided, especially in 
kitchens and bathrooms. 8 
NOISE 
Background noise may be a problem, particularly in institutions or 
shared houses. Conversations in a noisy environment ( eg with music 
playing or noisy appliances) should be avoided if the individual has 
any hearing impairment. 
MANUAL DEXTERITY 
Any decrease in manual dexterity may make opening bottles, jars and 
doors more difficult. This applies to the ageing carer just as much as 
to the individuals with a developmental disabihty. Opening 
childproof medication or blister packs may be problematic and in 
such cases the doctor can request medication is put in a Dosette® or 
similar container. 
MODIFICATIONS TO THE ENVIRONMENT 
Environmental modification and simple safety measures ( eg bathroom 
doors that open outwards, the addition of ramps and rails, equipment 
such as a wheelchair or scooter) may make the difference between a 
person remaining at home or being moved into institutional care. There 
is an obligation to support the person with a developmental disability or 
their ageing carer in obtaining environmental modification and 
equipment that will enable them to have an optimal quality of life. 
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